Inventor · disambiguated record
Barbara S. Fox
Also filed as: FOX BARBARA S · FOX BARBARA SAXTON
17 granted patents·30 pending applications·257 citations·filing 1995–2022
93Inventor score
Top patents by PatentIndex Score
47 records- 0190US5876727AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameIMMULOGIC PHARMA CORP·Filed 1996·Granted Mar 2, 1999·115 cites·18 claims
- 0284US8647626B2Compositions comprising TNF-specific antibodies for oral deliveryAVAXIA BIOLOGICS INC·Filed 2013·Granted Feb 11, 2014·5 cites·6 claims
- 0381US9078886B2Compositions for the treatment of addiction, psychiatric disorders, and neurodegenerative diseaseGOEDERS NICHOLAS E·Filed 2011·Granted Jul 14, 2015·8 cites·12 claims
- 0480US9079955B2Compositions comprising TNF-specific antibodies for oral delivery and methods of use thereof to treat inflammatory bowel diseaseAVAXIA BIOLOGICS INC·Filed 2014·Granted Jul 14, 2015·2 cites·14 claims
- 0580US8182818B2Methods of using anti-TNF antibodies for treating radiation damage to the digestive tractFOX BARBARA S·Filed 2010·Granted May 22, 2012·4 cites·22 claims
- 0680US5760184AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameIMMULOGIC PHARMA CORP·Filed 1995·Granted Jun 2, 1998·36 cites·8 claims
- 0778US5773003AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameIMMULOGIC INC·Filed 1995·Granted Jun 30, 1998·37 cites·12 claims
- 0872US5840307AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparationIMMULOGIC PHARMA CORP·Filed 1995·Granted Nov 24, 1998·21 cites·3 claims
- 0969US11230601B2Methods of using anti-lap antibodiesTILOS THERAPEUTICS INC·Filed 2018·Granted Jan 25, 2022·1 cites·14 claims
- 1068US2006286096A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1168US2006280736A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1268US2006286099A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1368US2006286097A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1468US2006286095A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1568US2006280735A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1667US6054127AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameIMMULOGIC PHARMA CORP·Filed 1997·Granted Apr 25, 2000·27 cites·7 claims
- 1767US2010105672A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameSWAIN PHILIP A·Filed 2009·Application pending·0 cites
- 1867US2010068222A1Hapten-carrier conjugates for use in drug abuse therapy and methods for preparation of sameSWAIN PHILIP A·Filed 2009·Application pending·0 cites
- 1964US2006286094A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 2064US2006058220A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2005·Application pending·0 cites
- 2163US2010209449A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameSWAIN PHILIP A·Filed 2010·Application pending·0 cites
- 2262US9987286B2Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative diseaseEMBERA NEUROTHERAPEUTICS INC·Filed 2015·Granted Jun 5, 2018·1 cites·12 claims
- 2362US2005124061A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2003·Application pending·0 cites
- 2461US2006286098A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 2560US8592560B2Antibodies to apical intestinal receptors and methods of treating metabolic diseaseFOX BARBARA S·Filed 2012·Granted Nov 26, 2013·0 cites·10 claims
- 2659US8435526B2Methods of treating mucositis using anti-TNF antibodiesFOX BARBARA S·Filed 2012·Granted May 7, 2013·0 cites·10 claims
- 2759US2014147446A1Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesityAVAXIA BIOLOGICS INC·Filed 2013·Application pending·0 cites
- 2858US2006239997A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 2958US2007154899A1Biodetection by nucleic acid-templated chemistryCOULL JAMES M·Filed 2006·Application pending·0 cites
- 3058US2002032316A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameCANTAB PHARMACEUTICALS RES LTD·Filed 2001·Application pending·0 cites
- 3157US2013084561A1Biodetection by nucleic acid-templated chemistryCOULL JAMES M·Filed 2012·Application pending·0 cites
- 3257US2022017612A1Anti-lap antibody variants and uses thereofTILOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3356US11130802B2Anti-lap antibody variantsTILOS THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·0 cites·18 claims
- 3456US8071101B2Antibody therapy for treatment of diseases associated with gluten intoleranceFOX BARBARA S·Filed 2006·Granted Dec 6, 2011·0 cites·10 claims
- 3556US2013324703A1Antibody therapy for use in the digestive tractAVAXIA BIOLOGICS INC·Filed 2013·Application pending·0 cites
- 3656US2017342149A1Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesityCIRCLE 33 LLC·Filed 2016·Application pending·0 cites
- 3755US8268971B2Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesityFOX BARBARA S·Filed 2010·Granted Sep 18, 2012·0 cites·6 claims
- 3855US2025032493A1Methods for Treating Diseases Using MALT1 InhibitorsRARIFIED BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3953US2003069400A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2002·Application pending·0 cites
- 4053US2014010822A1Antibody therapeutics with local activity in the digestive tractAVAXIA BIOLOGICS INC·Filed 2013·Application pending·0 cites
- 4151US8728471B2Antibody therapy for treatment of diseases associated with gluten intoleranceFOX BARBARA S·Filed 2011·Granted May 20, 2014·0 cites·14 claims
- 4251US2012258118A1Antibody therapeutics with local activity in the digestive tractFOX BARBARA S·Filed 2012·Application pending·0 cites
- 4351US2015252106A1Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesityAVAXIA BIOLOGICS INC·Filed 2015·Application pending·0 cites
- 4449US2017008957A1Antibody therapeutics with local activity in the digestive tractAVAXIA BIOLOGICS INCORPORATED·Filed 2016·Application pending·0 cites
- 4549US2015307604A1Antibody therapy for use in the digestive tractAVAXIA BIOLOGICS INC·Filed 2015·Application pending·0 cites
- 4639US2013058943A1Bovine polyclonal antibody specific for human tnfFOX BARBARA S·Filed 2012·Application pending·0 cites
- 4738US2012213796A1Polyclonal antibody compositionsFOX BARBARA S·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →